Company / R&D Expense
SS Innovations International, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.7M
FY2025
5-year range
$1.0K / $3.7M
FY2021-FY2025
Trend
+248.2%
vs FY2024
Sector context
#109 of 110
Health Care
What the data says
R&D Expense changed +248% YoY in FY2025, a notable deviation from the 9-year average annual change of +1056%.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +314.8%.
Improved from $1M to $4M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +253.7%
- 5-Year CAGR
- +314.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 110This company $3.7M Sector average $298.2M
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +314.8%, indicating consistent growth.
- In FY2025, r&d expense increased 248.2% year-over-year.
- Ranks #109 out of 110 companies in the Health Care sector.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7M | +248.2% |
| FY2024 | $1.1M | +0.0% |
| FY2023 | $1.1M | +1171.2% |
| FY2022 | $83.3K | +8228.2% |
| FY2021 | $1.0K | -66.7% |
| FY2020 | $3.0K | -95.1% |
| FY2019 | $60.9K | +124.4% |
| FY2018 | $27.1K | -61.9% |
| FY2017 | $71.2K | -44.2% |
| FY2016 | $127.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026